{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:15:44Z","timestamp":1758636944283},"reference-count":14,"publisher":"Societas Neurologica Japonica","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rinsho Shinkeigaku"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5692\/clinicalneurol.cn-001036","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T18:09:03Z","timestamp":1504116543000},"page":"515-520","source":"Crossref","is-referenced-by-count":5,"title":["Charcot-Marie-Tooth disease type 2 caused by homozygous &lt;i&gt;MME&lt;\/i&gt; gene mutation superimposed by chronic inflammatory demyelinating polyneuropathy"],"prefix":"10.5692","volume":"57","author":[{"given":"Miwako","family":"Fujisawa","sequence":"first","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medical Science"},{"name":"Department of Neurology, Yamaguchi Prefectural Grand Medical Center"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuteru","family":"Sano","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Omoto","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyun-ichi","family":"Ogasawara","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiaki","family":"Koga","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Takashima","sequence":"additional","affiliation":[{"name":"Department of Neurology and Geriatrics Kagoshima University Graduate School of Medical and Dental Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kanda","sequence":"additional","affiliation":[{"name":"Department of Neurology and Clinical Neuroscience, Yamaguchi University Graduate School of Medical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3663","reference":[{"key":"1","unstructured":"1) Hoyle JC, Isfort MC, Roggenbuck J, et al. The genetics of Charcot-Marie-Tooth disease: current trends and future implications for diagnosis and management. Appl Clin Genet 2015;8:235-243."},{"key":"2","doi-asserted-by":"crossref","unstructured":"3) Dyck PJ, Dyck JB, Engelstad J. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, editors. Peripheral Neuropathy. 4th ed. Philadelphia, Pennsylvania: WB Elsevier saunders; 2005. p. 733-829.","DOI":"10.1016\/B978-0-7216-9491-7.50035-1"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Higuchi Y, Hashiguchi A, Yuan J, et al. Mutations in <i>MME<\/i> cause an autosomal-recessive Charcot-Marie-Tooth Disease type2. Ann Neurol 2016;79:659-672.","DOI":"10.1002\/ana.24612"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Iwata N, Tsubuki S, Takaki Y, et al. Metabolic regulation of brain A\u03b2 by neprilysin. Science 2001;292:1550-1552.","DOI":"10.1126\/science.1059946"},{"key":"5","doi-asserted-by":"crossref","unstructured":"6) Li C, Booze RM, Hersh LB. Tissue-specific expression of rat neutral endopeptidase (neprilysin) mRNAs. J Biol Chem 1995;270:5723-5728.","DOI":"10.1074\/jbc.270.11.5723"},{"key":"6","doi-asserted-by":"crossref","unstructured":"7) Yasojima K, Akiyama H, McGeer EG, et al. Reduced neprilysin in high plaque areas of Alzheimer brain: a possible relationship to deficient degradation of \u03b2-amyloid peptide. Neurosci Lett 2001;297:97-100.","DOI":"10.1016\/S0304-3940(00)01675-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Ginsberg L, Malik O, Kenton AR, et al. Coexistent hereditary and inflammatory neuropathy. Brain 2004;127:193-202.","DOI":"10.1093\/brain\/awh017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Marques W Jr, Funayama CA, Secchin JB, et al. Coexistence of two chronic neuropathies in a young child: Charcot-Marie-Tooth disease type 1A and chronic inflammatory demyelinating polyneuropathy. Muscle Nerve 2010;42:598-600.","DOI":"10.1002\/mus.21753"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Mazzeo A, Stancanelli C, Russo M, et al. Subacute inflammatory demyelinating polyneuropathy disclosed by massive nerve root enhancement in CMT1A. Muscle Nerve 2012;45:451-452.","DOI":"10.1002\/mus.22260"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Kume K, Deguchi K, Ikeda K, et al. Usefulness of the modified F-ratio for assessments of proximal conduction in chronic inflammatory demyelinating polyneuropathy superimposed on Charcot Marie-Tooth disease type 1A. J Neurol Sci 2014;343:237-239.","DOI":"10.1016\/j.jns.2014.05.046"},{"key":"11","doi-asserted-by":"crossref","unstructured":"12) Watanabe M, Yamamoto N, Ohkoshi N, et al. Corticosteroid-responsive asymmetric neuropathy with a myelin protein zero gene mutation. Neurology 2002;59:767-769.","DOI":"10.1212\/WNL.59.5.767"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Houlden H, Laura M, Ginberg L, et al. The phenotype of Charcot-Marie-Tooth disease type 4C due to SH3TC2 mutations and possible predisposition to an inflammatory neuropathy. Neuromuscul Disord 2009;19:264-269.","DOI":"10.1016\/j.nmd.2009.01.006"},{"key":"13","doi-asserted-by":"crossref","unstructured":"14) Donaghy M, Sisodiya SM, Kennett R, et al. Steroid responsive polyneuropathy in a family with a novel myelin protein zero mutation. J Neurol Neurosurg Psychiatry 2000;69:799-805.","DOI":"10.1136\/jnnp.69.6.799"},{"key":"14","doi-asserted-by":"crossref","unstructured":"15) Yan WX, Archelos JJ, Hartung HP, et al. P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 2001;50:286-292.","DOI":"10.1002\/ana.1129"}],"container-title":["Rinsho Shinkeigaku"],"original-title":["\u6162\u6027\u708e\u75c7\u6027\u8131\u9ac4\u6027\u591a\u767a\u6839\u30cb\u30e5\u30fc\u30ed\u30d1\u30c1\u30fc\u3092\u5408\u4f75\u3057\u305f\uff0c&lt;i&gt;MME&lt;\/i&gt;\u907a\u4f1d\u5b50\u5909\u7570\u306b\u3088\u308b\u8ef8\u7d22\u578bCharcot-Marie-Tooth\u75c5\u306e59\u6b73\u7537\u6027\u4f8b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/57\/9\/57_cn-001036\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T19:36:23Z","timestamp":1570044983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/clinicalneurol\/57\/9\/57_cn-001036\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5692\/clinicalneurol.cn-001036","relation":{},"ISSN":["0009-918X","1882-0654"],"issn-type":[{"value":"0009-918X","type":"print"},{"value":"1882-0654","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}